Maleic Acid
Electron Microscopy Sciences Maleic Acid, Crystalline, Repurified, A.C.S. 250 GR
(Toxilic Acid; cis-Butenediodic Acid)
CAS #110-16-7 HOOCCH:CHCOOH F.W. 116.08
Assay: 99.5%
Boiling point: 132-134°C
Selleck Chemical LLC Maleic acid S3086-1g
Maleic acid inhibits glutamate decarboxylase (GAD) activity thus enhances acid sensitivity of Listeria monocytogenes Maleic acid affects the extracellular GABA levels
Medchemexpress LLC Maleic acid | 110-16-7 | MFCD00063177 | >98.0% | 116.07 | C4H4O4 | 5g
Maleic Acid is a Glutamate Decarboxylase (GAD) inhibitor of E coli and L monocytogenes
Sigma Aldrich Fine Chemicals Biosciences Maleic acid European Pharmacopoeia (EP) Reference Standard |
Maleic acid European Pharmacopoeia (EP) Reference Standard | Mol Wt: 116.07 |
U.S. Pharmacopeia Maleic acid, 110-16-7, MFCD00063177, 300 mg
Linear Formula: HO2CCH=CHCO2H, Molecular Weight: 116.07, mp: 137-140 °C, Synonym: cis-Butenedioic acid, Toxilic acid.
Medchemexpress LLC Prasugrel hydrochloride | 389574-19-0 | C20H21ClFNO3S | 1 ML
Prasugrel hydrochloride is a thienopyridine and proagent that inhibits platelet function. It is an orally active and potent P2Y12 receptor antagonist, inhibiting ADP-induced platelet aggregation. As an inactive prodrug, it requires metabolic processing to generate its active antiplatelet metabolite, which is rapidly absorbed from the gut.
- Thienopyridine and proagent
- Inhibits platelet function
- Orally active and potent P2Y12 receptor antagonist
- Inhibits ADP-induced platelet aggregation
- Acts faster and is significantly more potent than clopidogrel in vivo
- Requires metabolic processing to generate active antiplatelet metabolite
- Rapidly absorbed from the gut
- Maximum plasma levels of active metabolite achieved within 1 hour
- Effective, maximum inhibition of platelet aggregation at 1-2 hours
Selleck Chemical LLC PRX-08066 Maleic acid
PRX-08066 Maleic acid is a selective 5-HT2B receptor antagonist with IC50 of 3 4 nM prevents the severity of pulmonary arterial hypertension in the MCT rat model Phase 2
Medchemexpress LLC Prasugrel | 150322-43-3 | C20H20FNO3S | 500 MG
Prasugrel (PCR 4099) is a thienopyridine and proagent that inhibits platelet function. It acts as an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation. This inactive prodrug requires metabolic processing in vivo to generate the active antiplatelet metabolite.
- Inhibits platelet function.
- Orally active and potent P2Y12 receptor antagonist.
- Inhibits ADP-induced platelet aggregation.
- Acts faster and is significantly more potent than Clopidogrel in vivo.
- Rapidly absorbed from the gut.
- Effective maximum inhibition of platelet aggregation within 1-2 hours.